These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37657272)

  • 1. Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT
    Sudoł-Tałaj S; Kucwaj-Brysz K; Podlewska S; Kurczab R; Satała G; Mordyl B; Głuch-Lutwin M; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Czarnota-Łydka K; Kurowska K; Kubacka M; Żesławska E; Nitek W; Olejarz-Maciej A; Doroz-Płonka A; Partyka A; Latacz G; Wesołowska A; Handzlik J
    Eur J Med Chem; 2023 Nov; 260():115756. PubMed ID: 37657272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorine substituents and linker topology as factors of 5-HT
    Sudoł S; Kucwaj-Brysz K; Kurczab R; Wilczyńska N; Jastrzębska-Więsek M; Satała G; Latacz G; Głuch-Lutwin M; Mordyl B; Żesławska E; Nitek W; Partyka A; Buzun K; Doroz-Płonka A; Wesołowska A; Bielawska A; Handzlik J
    Eur J Med Chem; 2020 Oct; 203():112529. PubMed ID: 32693296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Triazine Derivatives as Serotonin 5-HT
    Łażewska D; Więcek M; Satała G; Chałupnik P; Żesławska E; Honkisz-Orzechowska E; Tarasek M; Latacz G; Nitek W; Szymańska E; Handzlik J
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exit beyond the pharmacophore model for 5-HT
    Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J
    Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT
    Czarnota-Łydka K; Sudoł-Tałaj S; Kucwaj-Brysz K; Kurczab R; Satała G; de Candia M; Samarelli F; Altomare CD; Carocci A; Barbarossa A; Żesławska E; Głuch-Lutwin M; Mordyl B; Kubacka M; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Partyka A; Khan N; Więcek M; Nitek W; Honkisz-Orzechowska E; Latacz G; Wesołowska A; Carrieri A; Handzlik J
    Eur J Med Chem; 2023 Nov; 259():115695. PubMed ID: 37567058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are the Hydantoin-1,3,5-triazine 5-HT
    Lubelska A; Latacz G; Jastrzębska-Więsek M; Kotańska M; Kurczab R; Partyka A; Marć MA; Wilczyńska D; Doroz-Płonka A; Łażewska D; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT
    Ali W; Więcek M; Łażewska D; Kurczab R; Jastrzębska-Więsek M; Satała G; Kucwaj-Brysz K; Lubelska A; Głuch-Lutwin M; Mordyl B; Siwek A; Nasim MJ; Partyka A; Sudoł S; Latacz G; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2019 Sep; 178():740-751. PubMed ID: 31229876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Marć MA; Satała G; Wilczyńska D; Kotańska M; Więcek M; Kamińska K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The computer-aided discovery of novel family of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV; Okun I; Aladinskiy V; Ivanenkov Y; Koryakova A; Karapetyan R; Mitkin O; Salimov R; Ivashchenko A
    J Alzheimers Dis; 2017; 58(4):1043-1063. PubMed ID: 28550249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
    Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
    ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models.
    Ivachtchenko AV; Ivanenkov YA; Veselov MS; Okun IM
    Curr Alzheimer Res; 2017; 14(3):268-294. PubMed ID: 27829340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer's Disease.
    Ivachtchenko AV; Lavrovsky Y; Ivanenkov YA
    Mol Pharm; 2016 Mar; 13(3):945-63. PubMed ID: 26886442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and computer-aided analysis of the role of linker for novel ligands of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Satała G; Kieć-Kononowicz K; Handzlik J
    Bioorg Chem; 2019 Mar; 84():319-325. PubMed ID: 30530073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitargeting the Action of 5-HT
    Czarnota-Łydka K; Kucwaj-Brysz K; Pyka P; Haberek W; Podlewska S; Handzlik J
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Phenoxyalkyltriazine Antagonists for 5-HT
    Sudoł S; Cios A; Jastrzębska-Więsek M; Honkisz-Orzechowska E; Mordyl B; Wilczyńska-Zawal N; Satała G; Kucwaj-Brysz K; Partyka A; Latacz G; Olejarz-Maciej A; Wesołowska A; Handzlik J
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual 5-HT
    Grychowska K; Chaumont-Dubel S; Kurczab R; Koczurkiewicz P; Deville C; Krawczyk M; Pietruś W; Satała G; Buda S; Piska K; Drop M; Bantreil X; Lamaty F; Pękala E; Bojarski AJ; Popik P; Marin P; Zajdel P
    ACS Chem Neurosci; 2019 Jul; 10(7):3183-3196. PubMed ID: 30896921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-Aided Studies for Novel Arylhydantoin 1,3,5-Triazine Derivatives as 5-HT₆ Serotonin Receptor Ligands with Antidepressive-Like, Anxiolytic and Antiobesity Action In Vivo.
    Kurczab R; Ali W; Łażewska D; Kotańska M; Jastrzębska-Więsek M; Satała G; Więcek M; Lubelska A; Latacz G; Partyka A; Starek M; Dąbrowska M; Wesołowska A; Jacob C; Kieć-Kononowicz K; Handzlik J
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30282913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical update on the potential for serotonin 5-HT
    Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
    Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.